gc33
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00746317)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glypican-3INHIBITOR
GPC3 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- gc33
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00976170 | Phase 1 | Sep 1, 2009 | Chugai, Roche |
| NCT00746317 | Phase 1 | Sep 1, 2008 | Chugai |
Showing 2 of 2 trials
Page 1 / 1